GLYCATED HEMOGLOBIN (HbA1C) - ANVISA Registration 80474870096

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80474870096 and manufactured by SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.. The registration is held by BIOSUL PRODUTOS DIAGNOSTICOS LTDA - ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80474870096
Registration Details
ANVISA Registration Number: 80474870096
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Kit de Reagentes HbA1c
Risk Class II

Registration Details

80474870096

25351809048202241

05905525000190

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Jun 02, 2022

VIGENTE

09/18/2025 19:00:01